CAS: 732278-52-3
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine REF: 3D-HEB27852CAS: 732278-52-3 | Min. 95% | Prezzo su richiesta | Mar 28 Gen 25 |
 | BDZ-g REF: TM-T62042CAS: 732278-52-3 | 98.77% | 113,00 €~1.052,00 € | Mar 18 Mar 25 |
(R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine
CAS:732278-52-3
Please enquire for more information about (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine including the price, delivery time and more detailed …
Formula:
C21H21N5O2S
Purezza:
Min. 95%
Peso molecolare:
407.5 g/mol
Ref: 3D-HEB27852
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 28 Gennaio 2025
BDZ-g
CAS:732278-52-3
BDZ-g: potent, selective AMPA receptor antagonist; useful for researching neurological disorders.
Formula:
C21H21N5O2S
Purezza:
98.77%
Colore e forma:
Liquid
Peso molecolare:
407.49
Ref: TM-T62042
| 1mg | 113,00 € | ||
| 5mg | 250,00 € | ||
| 10mg | 367,00 € | ||
| 25mg | 551,00 € | ||
| 50mg | 771,00 € | ||
| 100mg | 1.052,00 € | ||
| 1mL*10mM (DMSO) | 276,00 € |
Consegna stimata in Stati Uniti, il Martedì 18 Marzo 2025
